Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.00 HKD
−59.69 M HKD
2.06 B HKD
4.15 B
About SIHUAN PHARMACEUTICAL HOLD GP LTD
Sector
CEO
Wei Cheng Guo
Headquarters
Beijing
Website
Founded
2001
FIGI
BBG0016NP3X0
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 460 is 0.66 HKD — it hasn't changed in the past 24 hours. Watch SIHUAN PHARMACEUTICAL HOLD GP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SIHUAN PHARMACEUTICAL HOLD GP LTD stocks are traded under the ticker 460.
460 stock has fallen by −2.78% compared to the previous week, the month change is a −1.41% fall, over the last year SIHUAN PHARMACEUTICAL HOLD GP LTD has showed a −5.71% decrease.
460 stock is 9.23% volatile and has beta coefficient of 1.07. Track SIHUAN PHARMACEUTICAL HOLD GP LTD stock price on the chart and check out the list of the most volatile stocks — is SIHUAN PHARMACEUTICAL HOLD GP LTD there?
Today SIHUAN PHARMACEUTICAL HOLD GP LTD has the market capitalization of 6.48 B, it has increased by 4.48% over the last week.
Yes, you can track SIHUAN PHARMACEUTICAL HOLD GP LTD financials in yearly and quarterly reports right on TradingView.
SIHUAN PHARMACEUTICAL HOLD GP LTD is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
460 net income for the last half-year is −36.22 M HKD, while the previous report showed −4.72 M HKD of net income which accounts for −666.65% change. Track more SIHUAN PHARMACEUTICAL HOLD GP LTD financial stats to get the full picture.
As of Nov 22, 2024, the company has 2.87 K employees. See our rating of the largest employees — is SIHUAN PHARMACEUTICAL HOLD GP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIHUAN PHARMACEUTICAL HOLD GP LTD EBITDA is −42.21 M HKD, and current EBITDA margin is 1.27%. See more stats in SIHUAN PHARMACEUTICAL HOLD GP LTD financial statements.
Like other stocks, 460 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIHUAN PHARMACEUTICAL HOLD GP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIHUAN PHARMACEUTICAL HOLD GP LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIHUAN PHARMACEUTICAL HOLD GP LTD stock shows the sell signal. See more of SIHUAN PHARMACEUTICAL HOLD GP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.